These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 6797119)
41. Death of a hepatitis A patient during valproate therapy. Kamitani T; Takegoshi K; Okuda K; Okada E Am J Gastroenterol; 1991 May; 86(5):651. PubMed ID: 2028967 [No Abstract] [Full Text] [Related]
43. Case report: pancreatic pseudocyst associated with valproic acid therapy. Baskies AM J Med Soc N J; 1984 May; 81(5):399-400. PubMed ID: 6433023 [No Abstract] [Full Text] [Related]
44. Necrotizing pancreatitis after 10 years of therapy with valproic acid. Tobias JD; Capers C; Sims P; Holcomb GW Clin Pediatr (Phila); 1995 Aug; 34(8):446-8. PubMed ID: 7586914 [No Abstract] [Full Text] [Related]
45. Pancreatitis due to valproic acid. Camfield PR; Bagnell P; Camfield CS; Tibbles JA Lancet; 1979 Jun; 1(8127):1198-9. PubMed ID: 86928 [No Abstract] [Full Text] [Related]
46. Intraoperative defect in haemostasis in a child receiving valproic acid. Tetzlaff JE Can J Anaesth; 1991 Mar; 38(2):222-4. PubMed ID: 2021993 [TBL] [Abstract][Full Text] [Related]
47. Transient thrombocytopenia in a child on sodium valproate. Cole AP Dev Med Child Neurol; 1978 Aug; 20(4):487-90. PubMed ID: 357235 [No Abstract] [Full Text] [Related]
49. [Valproate--new data on metabolism and severe side effects]. Jameson S; Bjurstam N Lakartidningen; 1985 Feb; 82(9):679-81. PubMed ID: 3920457 [No Abstract] [Full Text] [Related]
50. Excipients in valproic acid syrup may cause diarrhea: a case report. Veerman MW DICP; 1990 Sep; 24(9):832-3. PubMed ID: 2260339 [TBL] [Abstract][Full Text] [Related]
51. Valproic acid and thrombocytopenia. Morris N; Barr RD; Pai KR; Kelton JG Can Med Assoc J; 1981 Jul; 125(1):63-4. PubMed ID: 6790153 [No Abstract] [Full Text] [Related]
52. Photosensitivity related to valproate withdrawal. Ambrosetto G; Tassinari CA J Neurol Neurosurg Psychiatry; 1987 Dec; 50(12):1709-10. PubMed ID: 3125308 [No Abstract] [Full Text] [Related]
53. Heterozygous alpha 1-antitrypsin deficiency and valproate hepatotoxicity. Moore JR; Williams TH; Talbot IC; Tanner MS Lancet; 1984 Jan; 1(8370):221. PubMed ID: 6141357 [No Abstract] [Full Text] [Related]
54. [Serum concentration of valproic acid after rectal administration]. Matsumura S; Shima T; Okada Y; Nishida M; Yamada T; Okita S; Kitayama K; Funaoka T Neurol Med Chir (Tokyo); 1988 May; 28(5):473-6. PubMed ID: 2471101 [No Abstract] [Full Text] [Related]
55. A very rare interference with the valproate method on the Beckman DxC 800 general chemistry analyser. Dimeski G; Treacy O; Marshall G Clin Chem Lab Med; 2019 Mar; 57(4):e67-e70. PubMed ID: 30157029 [No Abstract] [Full Text] [Related]
56. Serum valproate concentrations and control of seizures. Addy DP J Pediatr; 1992 Nov; 121(5 Pt 1):835-6. PubMed ID: 1432445 [No Abstract] [Full Text] [Related]
57. A case of valproate toxicity related to isoniazid. Stewart JT; Nesmith MW; Mattox KM J Clin Psychopharmacol; 2012 Dec; 32(6):840-1. PubMed ID: 23131873 [No Abstract] [Full Text] [Related]
58. Side effects of sodium valproate. Bellmann MH; Ross EM Br Med J; 1977 Jun; 1(6077):1662. PubMed ID: 326341 [No Abstract] [Full Text] [Related]